Search by Drug Name or NDC

NDC 76045-0121-11 Dilaudid 0.2 mg/mL Details

Dilaudid 0.2 mg/mL

Dilaudid is a INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is HYDROMORPHONE HYDROCHLORIDE.

MedlinePlus Drug Summary

Hydromorphone injection is used to relieve pain. Hydromorphone injection is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.

Related Packages: 76045-0121-11
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Hydromorphone Injection

Product Information

NDC	76045-0121
Product ID	76045-121_d2fe0d3b-8eb6-4e54-8418-642f330abbf7
Associated GPIs	65100035102002
GCN Sequence Number	081024
GCN Sequence Number Description	hydromorphone HCl/PF SYRINGE 0.2 MG/ML INJECTION
HIC3	H3A
HIC3 Description	OPIOID ANALGESICS
GCN	48024
HICL Sequence Number	034805
HICL Sequence Number Description	HYDROMORPHONE HCL/PF
Brand/Generic	Brand
Proprietary Name	Dilaudid
Proprietary Name Suffix	n/a
Non-Proprietary Name	Hydromorphone hydrochloride
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION
Route	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Active Ingredient Strength	0.2
Active Ingredient Units	mg/mL
Substance Name	HYDROMORPHONE HYDROCHLORIDE
Labeler Name	Fresenius Kabi USA, LLC
Pharmaceutical Class	Full Opioid Agonists [MoA], Opioid Agonist [EPC]
DEA Schedule	CII
Marketing Category	NDA
Application Number	NDA019034
Listing Certified Through	2025-12-31

Package

NDC 76045-0121-11 (76045012111)

Pricing Information	N/A
NDC Package Code	76045-121-11
Billing NDC	76045012111
Package	10 SYRINGE in 1 CARTON (76045-121-11) / 1 mL in 1 SYRINGE (76045-121-01)
Marketing Start Date	2020-01-16
NDC Exclude Flag	N